Oncology - Medicine.net

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe

Updated on: June 01,2024

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe

Updated on:June 01,2024

Future cancer treatment and fertility discussed in comprehensive review

by Karolinska InstitutetCredit:European Journal of Cancer(2024). DOI: 10.1016/j.ejca.2024.114010In recent years, the treatment landscape for solid tumors has undergone a notable chang

Updated on: March 20,2024

Future cancer treatment and fertility discussed in comprehensive review

by Karolinska InstitutetCredit:European Journal of Cancer(2024). DOI: 10.1016/j.ejca.2024.114010In recent years, the treatment landscape for solid tumors has undergone a notable chang

Updated on:March 20,2024

Super-soldier T-cells fight cancer better after a transformational DNA delivery

by Andy Tay,The ConversationCredit: Ketut Subiyanto from PexelsI enjoy online shopping. However, I often find myself fussing about the delivery options during checkout. This is because not all d

Updated on: April 01,2024

Super-soldier T-cells fight cancer better after a transformational DNA delivery

by Andy Tay,The ConversationCredit: Ketut Subiyanto from PexelsI enjoy online shopping. However, I often find myself fussing about the delivery options during checkout. This is because not all d

Updated on:April 01,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on: January 12,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on:January 12,2024

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on: March 25,2024

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on:March 25,2024

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on: January 26,2024

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on:January 26,2024

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on: January 29,2024

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on:January 29,2024

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on: January 25,2024

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on:January 25,2024

Vigilant monitoring is needed to manage cardiac risks in patients using antipsychotics, doctors say

by ElsevierCredit: Unsplash/CC0 Public DomainThe use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death

Updated on: May 06,2024

Vigilant monitoring is needed to manage cardiac risks in patients using antipsychotics, doctors say

by ElsevierCredit: Unsplash/CC0 Public DomainThe use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death

Updated on:May 06,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on: January 16,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on:January 16,2024

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with